CASC2 and central nervous system cancer: In gliomas, lncRNA CASC2 was displayed as an inhibitor of cell growth through negatively modulating miR-21, whereas lncRNA CRNDE induced cell growth and invasion of glioma via modulating mTOR signaling [12].